|Antidiabetic therapies affect risk of pancreatic cancer|
D Li, SCJ Yeung, MM Hassan, M Konopleva, JL Abbruzzese
Gastroenterology 137 (2), 482-488, 2009
|Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alfa-2b|
JC Yao, A Phan, PM Hoff, HX Chen, C Charnsangavej, SCJ Yeung, ...
Journal of Clinical Oncology 26 (8), 1316-1323, 2008
|Metformin use is associated with better survival of diabetic patients with pancreatic cancer|
N Sadeghi, JL Abbruzzese, SCJ Yeung, M Hassan, D Li
Clinical cancer research 18 (10), 2905-2912, 2012
|Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies|
LM Phan, SCJ Yeung, MH Lee
Cancer biology & medicine 11 (1), 1, 2014
|Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer|
BA Schiff, AB McMurphy, SA Jasser, MN Younes, D Doan, OG Yigitbasi, ...
Clinical cancer research 10 (24), 8594-8602, 2004
|Tumor‐specific changes in mtDNA content in human cancer|
E Mambo, A Chatterjee, M Xing, G Tallini, BR Haugen, SCJ Yeung, ...
International journal of cancer 116 (6), 920-924, 2005
|Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells|
SCJ Yeung, G Xu, J Pan, M Christgen, A Bamiagis
Cancer research 60 (3), 650-656, 2000
|Aurora B kinase phosphorylates and instigates degradation of p53|
CP Gully, G Velazquez-Torres, JH Shin, E Fuentes-Mattei, E Wang, ...
Proceedings of the National Academy of Sciences 109 (24), E1513-E1522, 2012
|Roles of COP9 signalosome in cancer|
MH Lee, R Zhao, L Phan, SCJ Yeung
Cell cycle 10 (18), 3057-3066, 2011
|Farnesyltransferase inhibitors induce DNA damage via reactive oxygen species in human cancer cells|
J Pan, M She, ZX Xu, L Sun, SCJ Yeung
Cancer research 65 (9), 3671-3681, 2005
|Angiogenesis Inhibition in the in Vivo Antineoplastic Effect of Manumycin and Paclitaxel against Anaplastic Thyroid Carcinoma|
G Xu, J Pan, C Martin, SCJ Yeung
The Journal of Clinical Endocrinology & Metabolism 86 (4), 1769-1777, 2001
|Clinical and organizational factors in the initial evaluation of patients with lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians …|
DE Ost, SCJ Yeung, LT Tanoue, MK Gould
Chest 143 (5), e121S-e141S, 2013
|Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation …|
W Liao, SCJ Yeung, L Chan
Journal of Biological Chemistry 273 (42), 27225-27230, 1998
|Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells|
Q Jin, LX Yuan, D Boulbes, JM Baek, YN Wang, D Gomez-Cabello, ...
Breast Cancer Research 12 (6), R96, 2010
|Clinical and in vitro studies of imatinib in advanced carcinoid tumors|
JC Yao, JX Zhang, A Rashid, SCJ Yeung, J Szklaruk, K Hess, K Xie, ...
Clinical cancer research 13 (1), 234-240, 2007
|Cytochrome c Release Is Upstream to Activation of Caspase-9, Caspase-8, and Caspase-3 in the Enhanced Apoptosis of Anaplastic Thyroid Cancer Cells Induced …|
J Pan, G Xu, SCJ Yeung
The Journal of Clinical Endocrinology & Metabolism 86 (10), 4731-4740, 2001
|Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers|
R Zhao, SCJ Yeung, J Chen, T Iwakuma, CH Su, B Chen, C Qu, F Zhang, ...
The Journal of clinical investigation 121 (3), 851-865, 2011
|Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation|
J Chen, M Kobayashi, S Darmanin, Y Qiao, C Gully, R Zhao, S Kondo, ...
The American journal of pathology 175 (1), 400-411, 2009
|Combination chemotherapy including combretastatin A4 phosphate and paclitaxel is effective against anaplastic thyroid cancer in a nude mouse xenograft model|
SCJ Yeung, M She, H Yang, J Pan, L Sun, D Chaplin
The Journal of Clinical Endocrinology & Metabolism 92 (8), 2902-2909, 2007
|Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer|
CP Gully, F Zhang, J Chen, JA Yeung, G Velazquez-Torres, E Wang, ...
Molecular cancer 9 (1), 42, 2010